Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!
NING Wei-wei, LIU Xue-fei, ZHANG Xiao-meng, ZHENG Can-hui, SHENG Chun-quan, ZHOU You-jun, ZHANG Ling, LV Jia-guo, ZHU Ju. Design,synthesis of novel quinazolinon compounds as human anti-acrosin inhibitor[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 296-298,312.
Citation:
HOU Ming-ming, SONG Hong-tao, WANG Qing-hua, YANG Shun-liang, TAN Jian-ming. Effect of MDR1C3435T genetic polymorphism on concentration/dose and efficacy of tacrolimus in patients with kidney transplantation[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(1): 29-31.
Effect of MDR1C3435T genetic polymorphism on concentration/dose and efficacy of tacrolimus in patients with kidney transplantation
Department of Pharmacy,Fuzhou General Hospital of Nanjing Military Region,Fuzhou 350025,China;School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China
2.
Department of Pharmacy,Fuzhou General Hospital of Nanjing Military Region,Fuzhou 350025,China
3.
Department of Urology,Fuzhou General Hospital of Nanjing Military Region,Fuzhou 350025,China
Received Date: 2009-06-29
Rev Recd Date:
2009-08-18
Abstract
Objective To investigate the impact of MDR1C3435T genetic polymorphism on the concentration/dose(C/D) ratio,acute rejection and adverse effect of tacrolimus(FK506)in the renal patients after transplantation. Methods The MDR1C3435T genotype was determined by PCR-RFLP method.The differences of C/D ratio,acute rejection and adverse reaction were compared among all of the genotype groups treated with FK506. Results There was no significant difference in the C/D ratio,rejection and adverse reaction of FK506 among MDR1C3435T genotype groups. Conclusion There was no significant relation between the C/D ratio,acute rejection and adverse reaction of FK506 and MDR1C3435T genetic polymorphism in the transplant patients.
1. Department of Pharmacy,Fuzhou General Hospital of Nanjing Military Region,Fuzhou 350025,China;School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China
2. Department of Pharmacy,Fuzhou General Hospital of Nanjing Military Region,Fuzhou 350025,China
3. Department of Urology,Fuzhou General Hospital of Nanjing Military Region,Fuzhou 350025,China
Abstract: Objective To investigate the impact of MDR1C3435T genetic polymorphism on the concentration/dose(C/D) ratio,acute rejection and adverse effect of tacrolimus(FK506)in the renal patients after transplantation. Methods The MDR1C3435T genotype was determined by PCR-RFLP method.The differences of C/D ratio,acute rejection and adverse reaction were compared among all of the genotype groups treated with FK506. Results There was no significant difference in the C/D ratio,rejection and adverse reaction of FK506 among MDR1C3435T genotype groups. Conclusion There was no significant relation between the C/D ratio,acute rejection and adverse reaction of FK506 and MDR1C3435T genetic polymorphism in the transplant patients.
NING Wei-wei, LIU Xue-fei, ZHANG Xiao-meng, ZHENG Can-hui, SHENG Chun-quan, ZHOU You-jun, ZHANG Ling, LV Jia-guo, ZHU Ju. Design,synthesis of novel quinazolinon compounds as human anti-acrosin inhibitor[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 296-298,312.
Citation:
HOU Ming-ming, SONG Hong-tao, WANG Qing-hua, YANG Shun-liang, TAN Jian-ming. Effect of MDR1C3435T genetic polymorphism on concentration/dose and efficacy of tacrolimus in patients with kidney transplantation[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(1): 29-31.
HTML
Catalog
HTML
Export File
Citation
NING Wei-wei, LIU Xue-fei, ZHANG Xiao-meng, ZHENG Can-hui, SHENG Chun-quan, ZHOU You-jun, ZHANG Ling, LV Jia-guo, ZHU Ju. Design,synthesis of novel quinazolinon compounds as human anti-acrosin inhibitor[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 296-298,312.
NING Wei-wei, LIU Xue-fei, ZHANG Xiao-meng, ZHENG Can-hui, SHENG Chun-quan, ZHOU You-jun, ZHANG Ling, LV Jia-guo, ZHU Ju. Design,synthesis of novel quinazolinon compounds as human anti-acrosin inhibitor[J]. Journal of Pharmaceutical Practice and Service, 2010, 28(4): 296-298,312.